Any word on the Q3 earnings call impact?

Hey everyone, just wondering if anyone has heard any whispers or has any insights into what the recent Q3 earnings call might mean for us here at GE HealthCare. I know they talked about some restructuring and cost-saving measures, but it felt pretty vague in the investor call. Usually, after these calls, there's some internal comms or at least a bit of chatter, but it's been quiet. Anyone in finance or strategy have any intel? Trying not to spiral, but the uncertainty is starting to get to me. Just looking for some clarity or even just to know if anyone else is feeling the same way.